Comparing the Effectiveness of Different Appointment Reminder Methods

April 1, 2025 updated by: M. Kit Delgado, MD

Comparative Effectiveness of Targeted Outreach With an Automated Caller for Increasing Appointment Completion: A Randomized Quality Improvement Initiative

Penn Medicine is continually trying to optimize operations and decrease number of patients who do not show up for their appointments. This has included new changes to text message reminders, implemented as usual care. At a baseline, less than 75% of scheduled outpatient appointments are actually completed. This results in longer wait times and decreased access for patients and operational inefficiencies. The goal of the project is to test whether supplementing standard text message appointment reminders with targeted outreach using an automated phone call to patients with increased risk of not showing up for their appointment (>15% per Epic's Risk of Patient No-Show Model) reduces no show rate (the study's primary outcome) and increases patient appointment completion rate (% of appointments that were completed during scheduled appointment time, a secondary outcome). Participants will be randomized in a 1:1 ratio to receive either the standard text message or standard text message plus the automated caller. Eligible patients have already consented to receiving text message reminders from Penn Medicine and must have an in-person appointment scheduled during the study period. The Access Optimization Group at Penn will be monitoring the randomization and outcomes reporting of whether a patient confirmed, cancelled, or no showed at the scheduled appointment. All eligible outpatient appointments over a two week period will be included in this operational evaluation. The Access Optimization Group will then make a decision on which approach to implement as usual care based on the results of this operational evaluation.

Study Overview

Status

Completed

Study Type

Interventional

Enrollment (Actual)

32925

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Pennsylvania
      • Philadelphia, Pennsylvania, United States, 19104
        • Penn Medicine

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • in-person appointments
  • English or Spanish speakers
  • 18 years old or older

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Other
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
No Intervention: Text Message (Usual Care)
Standard text message appointment reminders to English and Spanish-speaking patients. Text reminders will go out 3-weeks, 3 days, and 24 hours before the appointment.
Active Comparator: Text Message + Automated Caller (Intervention)
Standard text message appointment reminders to English and Spanish-speaking patients. Text reminders will go out 3-weeks, 3 days, and 24 hours before the appointment. If patient has not confirmed their appointment after the 3-week and 3-day reminders, they'll receive an automated caller.
Standard text message appointment reminders to English and Spanish-speaking patients. Text reminders will go out 3-weeks, 3 days, and 24 hours before the appointment. If patient has not confirmed their appointment after the 3-week and 3-day reminders they will receive an automated caller.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
No Show Rate
Time Frame: Through study completion, on average of 3 weeks
Proportion of initially scheduled appointments in which the patient did not show.
Through study completion, on average of 3 weeks

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Appointment Completion Rate
Time Frame: Through study completion, on average of 3 weeks
Proportion of initial scheduled appointments completed.
Through study completion, on average of 3 weeks
Appointment Cancelation Rate
Time Frame: Through study completion, on average of 3 weeks
Proportion of initially scheduled appointments cancelled.
Through study completion, on average of 3 weeks
Appointment Refill Rate
Time Frame: Through study completion, on average of 3 weeks
Proportion of cancelled appointments that were refilled.
Through study completion, on average of 3 weeks
Refilled Appointment Completion Ration
Time Frame: Through study completion, on average of 3 weeks
Proportion of refilled appointments that were completed.
Through study completion, on average of 3 weeks
Net Appointment Completion Rate
Time Frame: Through study completion, on average of 3 weeks
Proportion of appointment slots resulting in a completed appointment. Includes completed refilled appointments.
Through study completion, on average of 3 weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

November 5, 2024

Primary Completion (Actual)

December 5, 2024

Study Completion (Actual)

February 5, 2025

Study Registration Dates

First Submitted

November 13, 2024

First Submitted That Met QC Criteria

January 5, 2025

First Posted (Actual)

January 9, 2025

Study Record Updates

Last Update Posted (Actual)

April 4, 2025

Last Update Submitted That Met QC Criteria

April 1, 2025

Last Verified

April 1, 2025

More Information

Terms related to this study

Other Study ID Numbers

  • IRB # 855257

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Appointment Reminders

Clinical Trials on Text Message + Automated Caller (Intervention)

Subscribe